Doug Evans

Doug Evans possesses extensive leadership experience in the medical technology field, currently serving as President & CEO of Lungpacer Medical Inc. since January 2014, where innovative therapies for critically ill patients are being developed. As a Board Member of WhiteSwell since January 2016 and Chairman of the Board of TELA Bio since April 2020, Doug Evans is focused on advancing treatment for heart failure and tissue reinforcement, respectively. Co-founding the Cure4Cam Childhood Cancer Foundation in January 2012 underscores a commitment to addressing childhood cancer. Previous roles include Board Observer at Vesper Medical, Inc., Board Member and Executive Director at Intact Vascular, and COO/Board Member at Kensey Nash Corporation, contributing to significant advancements in medical devices. Doug Evans holds a Master's degree in Electrical Engineering and Photonics from the University of Pennsylvania, a Bachelor's degree in Engineering Science with Honors in Bioengineering from Penn State University, and an MBA from the Penn State Smeal MBA Program.